Brian Rini

Brian Rini

Vanderbilt University - Nashville / United States
Others
AD Scientific Index ID: 4701227
person_outline Brian Rini's MOST POPULAR ARTICLES
1-) Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinomaRJ Motzer, NM Tannir, DF McDermott, OA Frontera, B Melichar, ...New England Journal of Medicine, 201830702018
2-) Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinomaBI Rini, ER Plimack, V Stus, R Gafanov, R Hawkins, D Nosov, F Pouliot, ...New England Journal of Medicine 380 (12), 1116-1127, 201921252019
3-) Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinomaRJ Motzer, K Penkov, J Haanen, B Rini, L Albiges, MT Campbell, ...New England Journal of Medicine 380 (12), 1103-1115, 201923532019
4-) Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results from a large …DYC Heng, W Xie, MM Regan, MA Warren, AR Golshayan, C Sahi, ...Journal of clinical oncology 27 (34), 5794-5799, 200923522009
5-) Renal cell carcinomaBI Rini, SC Campbell, B EscudierThe Lancet 373 (9669), 1119-1132, 200922562009